Global Burden of Thrombosis: Epidemiologic Aspects

Circulation Research

Volumn 118, Issue 9, 2016, Pages 1340-1347

  Wendelboe, Aaron M ^a   Raskob, Gary E ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

atrial fibrillation; myocardial infarction; pulmonary embolism; stroke; venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; ESTROGEN; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ACUTE HEART INFARCTION; ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CANCER SURGERY; CARDIOVASCULAR MORTALITY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; GENE MUTATION; GROUPS BY AGE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; IMMOBILIZATION; INCIDENCE; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; META ANALYSIS (TOPIC); OBESITY; PATIENT HISTORY OF SURGERY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW (TOPIC); TOBACCO CONSUMPTION; TOBACCO USE; VENOUS THROMBOEMBOLISM; COMPLICATION; FEMALE; GLOBAL DISEASE BURDEN; MALE; META ANALYSIS; MORTALITY; MYOCARDIAL INFARCTION; PULMONARY EMBOLISM; SOCIOECONOMICS; STROKE; THROMBOSIS;

ATRIAL FIBRILLATION; FEMALE; GLOBAL BURDEN OF DISEASE; HUMANS; MALE; MYOCARDIAL INFARCTION; PULMONARY EMBOLISM; SOCIOECONOMIC FACTORS; STROKE; THROMBOSIS;

EID: 84968584117     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.306841     Document Type: Article

References (53)

1. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost. 2014;12:1580-1590.
2. Schulman S, Marder VJ. Overview of arterial thrombotic disorders. In: V. J. Marder, W. C. Aird, J. S. Bennett, S. Schulman, G. C. White, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice Philidelphia, PA: Wolters Kluwer; 2013: 1043-1046.
3. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128. doi: 10.1016/S0140-6736(12)61728-0.
4. Fuster V, Kovacic JC. Acute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatment. Circ Res. 2014;114:1847-1851. doi: 10.1161/CIRCRESAHA.114.302806.
5. Parikh NI, Gona P, Larson MG, Fox CS, Benjamin EJ, Murabito JM, O'Donnell CJ, Vasan RS, Levy D. Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study. Circulation. 2009;119:1203-1210. doi: 10.1161/CIRCULATIONAHA.108.825364.
6. Rosamond WD, Chambless LE, Heiss G, Mosley TH, Coresh J, Whitsel E, Wagenknecht L, Ni H, Folsom AR. Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008. Circulation. 2012;125:1848-1857. doi: 10.1161/CIRCULATIONAHA.111.047480.
7. Types of Stroke. http://www.strokeassociation.org/STROKEORG/About Stroke/TypesofStroke/Types-of-Stroke-UCM-308531-SubHomePage. jsp.
8. Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114:1453-1468. doi: 10.1161/CIRCRESAHA.114.303211.
9. Schulman S, Marder VJ, Whitsett C. Overivew of venous thromboembolism. In: V. J. Marder, W. C. Aird, J. S. Bennett, S. Schulman, G. C. White, eds. Hemostatis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Wolters Kluwer; 2013: 957-961.
10. Leibson CL, Needleman J, Buerhaus P, Heit JA, Melton LJ III, Naessens JM, Bailey KR, Petterson TM, Ransom JE, Harris MR. Identifying inhospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort. Med Care. 2008;46:127-132. doi: 10.1097/MLR.0b013e3181589b92.
11. Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743-800.
12. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837-847. doi: 10.1161/CIRCULATIONAHA.113.005119.
13. Alonso A, Bengtson LG. A rising tide: the global epidemic of atrial fibrillation. Circulation. 2014;129:829-830. doi: 10.1161/CIRCULATIONAHA.113.007482.
14. Wendelboe AM, McCumber M, Hylek EM, Buller H, Weitz JI, Raskob G; ISTH Steering Committee for World Thrombosis Day. Global public awareness of venous thromboembolism. J Thromb Haemost. 2015;13:1365-1371. doi: 10.1111/jth.13031.
15. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003;163:1711-1717. doi: 10.1001/archinte.163.14.1711.
16. Venous Thromboembolism (Blood Clots): Data & Statistics. http://www. cdc.gov/ncbddd/dvt/data.html.
17. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Flaxman A, Murray CJ, Naghavi M. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129:1493-1501. doi: 10.1161/CIRCULATIONAHA.113.004046.
18. Bennett DA, Krishnamurthi RV, Barker-Collo S, Forouzanfar MH, Naghavi M, Connor M, Lawes CM, Moran AE, Anderson LM, Roth GA, Mensah GA, Ezzati M, Murray CJ, Feigin VL; Global Burden of Diseases, Injuries, and Risk Factors 2010 Study Stroke Expert Group. The global burden of ischemic stroke: findings of the GBD 2010 study. Glob Heart. 2014;9:107-112. doi: 10.1016/j.gheart.2014.01.001.
19. Jha AK, Larizgoitia I, Audera-Lopez C, Prasopa-Plaizier N, Waters H, Bates DW. The global burden of unsafe medical care: analytic modelling of observational studies. BMJ Qual Saf. 2013;22:809-815. doi: 10.1136/bmjqs-2012-001748.
20. Ahmad O, Boschi-Pinto C, Lopez A, Murray C, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. 2001;31. http://www.who. int/healthinfo/paper31.pdf.
21. Mozaffarian D, Benjamin EJ, Go AS, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131:e29-322. doi: 10.1161/CIR.0000000000000152.
22. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, Naghavi M. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129:1483-1492. doi: 10.1161/CIRCULATIONAHA.113.004042.
23. Moran AE, Tzong KY, Forouzanfar MH, Rothy GA, Mensah GA, Ezzati M, Murray CJ, Naghavi M. Variations in ischemic heart disease burden by age, country, and income: the Global Burden of Diseases, Injuries, and Risk Factors 2010 study. Glob Heart. 2014;9:91-99. doi: 10.1016/j. gheart.2013.12.007.
24. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al.; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245-254.
25. Marcus JL, Leyden WA, Chao CR, Chow FC, Horberg MA, Hurley LB, Klein DB, Quesenberry CP Jr, Towner WJ, Silverberg MJ. HIV infection and incidence of ischemic stroke. AIDS. 2014;28:1911-1919. doi: 10.1097/QAD.0000000000000352.
26. Koton S, Schneider AL, Rosamond WD, Shahar E, Sang Y, Gottesman RF, Coresh J. Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA. 2014;312:259-268. doi: 10.1001/jama.2014.7692.
27. Chau PH, Woo J, Goggins WB, Tse YK, Chan KC, Lo SV, Ho SC. Trends in stroke incidence in Hong Kong differ by stroke subtype. Cerebrovasc Dis. 2011;31:138-146. doi: 10.1159/000321734.
28. Xu J, Xu T, Bu X, Peng H, Li H, Zhang M, Zhang Y. The predictive value of waist-to-height ratio for ischemic stroke in a population-based prospective cohort study among Mongolian men in China. PLoS One. 2014;9:e110245. doi: 10.1371/journal.pone.0110245.
29. Fang MC, Coca Perraillon M, Ghosh K, Cutler DM, Rosen AB. Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008. Am J Med. 2014;127:608-615. doi: 10.1016/j.amjmed.2014.03.017.
30. Morgenstern LB, Smith MA, Sánchez BN, Brown DL, Zahuranec DB, Garcia N, Kerber KA, Skolarus LE, Meurer WJ, Burke JF, Adelman EE, Baek J, Lisabeth LD. Persistent ischemic stroke disparities despite declining incidence in Mexican Americans. Ann Neurol. 2013;74:778-785. doi: 10.1002/ana.23972.
31. Maaijwee NA, Rutten-Jacobs LC, Schaapsmeerders P, van Dijk EJ, de Leeuw FE. Ischaemic stroke in young adults: risk factors and longterm consequences. Nat Rev Neurol. 2014;10:315-325. doi: 10.1038/nrneurol.2014.72.
32. Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, Wolf PA. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA. 2006;296:2939-2946. doi: 10.1001/jama.296.24.2939.
33. Shahar E, McGovern PG, Sprafka JM, Pankow JS, Doliszny KM, Luepker RV, Blackburn H. Improved survival of stroke patients during the 1980s. The Minnesota Stroke Survey. Stroke. 1995;26:1-6.
34. Vangen-Lønne AM, Wilsgaard T, Johnsen SH, Carlsson M, Mathiesen EB. Time trends in incidence and case fatality of ischemic stroke: the tromsø study 1977-2010. Stroke. 2015;46:1173-1179. doi: 10.1161/STROKEAHA.114.008387.
35. Carter KN, Anderson CS, Hackett ML, Barber PA, Bonita R; Auckland Regional Community Stroke Study Group. Improved survival after stroke: is admission to hospital the major explanation? Trend analyses of the Auckland Regional Community Stroke Studies. Cerebrovasc Dis. 2007;23:162-168. doi: 10.1159/000097054.
36. Rothwell PM, Coull AJ, Giles MF, et al; Oxford Vascular Study. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004;363:1925-1933. doi: 10.1016/S0140-6736(04)16405-2.
37. Islam MS, Anderson CS, Hankey GJ, Hardie K, Carter K, Broadhurst R, Jamrozik K. Trends in incidence and outcome of stroke in Perth, Western Australia during 1989 to 2001: the Perth Community Stroke Study. Stroke. 2008;39:776-782. doi: 10.1161/STROKEAHA.107.493643.
38. Compressed Mortality File 1999-2009. http://wonder.cdc.gov/mortsql. html.
39. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
40. Gbadebo TD, Okafor H, Darbar D. Differential impact of race and risk factors on incidence of atrial fibrillation. Am Heart J. 2011;162:31-37. doi: 10.1016/j.ahj.2011.03.030.
41. Kelly PJ. Preventing the rise of atrial fibrillation-related stroke in populations: a call to action. Circulation. 2014;130:1221-1222. doi: 10.1161/CIRCULATIONAHA.114.012738.
42. Yiin GS, Howard DP, Paul NL, Li L, Luengo-Fernandez R, Bull LM, Welch SJ, Gutnikov SA, Mehta Z, Rothwell PM; Oxford Vascular Study. Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study. Circulation. 2014;130:1236-1244. doi: 10.1161/CIRCULATIONAHA.114.010942.
43. Woo KS, Tse LK, Tse CY, Metreweli C, Vallance-Owen J. The prevalence and pattern of pulmonary thromboembolism in the Chinese in Hong Kong. Int J Cardiol. 1988;20:373-380.
44. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation. 2010;121:1896-1903. doi: 10.1161/CIRCULATIONAHA.109.921460.
45. Cheuk BL, Cheung GC, Cheng SW. Epidemiology of venous thromboembolism in a Chinese population. Br J Surg. 2004;91:424-428. doi: 10.1002/bjs.4454.
46. Venous thromboembolism in adult hospitalizations-United States, 2007-2009. MMWR Morbid Mortal Wkly Rep. 2012;61:401-404.
47. Jang MJ, Bang SM, Oh D. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost. 2011;9:85-91. doi: 10.1111/j.1538-7836.2010.04108.x.
48. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232:155-160.
49. Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12:464-474. doi: 10.1038/nrcardio.2015.83.
50. Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost. 2010;8:2105-2112. doi: 10.1111/j.1538-7836.2010.03986.x.
51. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38:S495-S501. doi: 10.1016/j.amepre.2009.12.017.
52. Heit JA, Cohen AA and Anderson FJ. Estimated annual number of incident and recurrent non-fatal and fatal venous thromboembolism (VTE) events in the US. American Society of Hematology. 2005;106:267A.
53. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756-764.